ViaDerm hPTH: Phase IIa data

Data from a 3-month, international Phase IIa trial in 104 postmenopausal women with osteoporosis showed that ViaDerm-hPTH(1-34) met the primary endpoint of an increase from baseline in PINP levels. T...